Introduction
Mouse two-stage skin carcinogenesis is under polygenic control, with several loci affecting strain susceptibility/ resistance (Dragani, 2003) . We have previously mapped, on central Chromosome 7, a modifier locus of two-stage skin carcinogenesis in a Mus musculus intercross between two outbred mouse lines characterized, respectively, by extremely high (Car-S) and low (Car-R) susceptibility to two-stage skin carcinogenesis (Peissel et al., 2001) . These genetically heterogeneous outbred mice provide high-resolution mapping and placed the peak LOD score for the Chromosome 7 locus in a o5.5 cM region near the Tyr gene (Peissel et al., 2001) . Moreover, all the tumor susceptible Car-S mice are albino and carry, in a 6 cM region that included the Tyr locus, a specific haplotype identical by descend to that of albino progenitor strains, whereas resistant Car-R mice show heterogeneous haplotype and pigmented coat colors (Peissel et al., 2000; Saran et al., 2000) . The susceptibility allele of the Car-R/Car-S locus derives from the albino Car-S line and shows a recessive inheritance pattern (Peissel et al., 2001) .
In the same chromosomal region that includes the Tyr locus, the Skts1 locus was mapped, affecting the genetic control of susceptibility/resistance to chemically induced skin carcinogenesis in an interspecific backcross (Nagase et al., 1995) . The tumor susceptibility allele of the Skts1 locus derives from the albino Mus musculus strain (Nagase et al., 1995) . However, the peak LOD score for Skts1 seems more proximal than the Tyr locus, and in fact it is not within the 5.5 cM interval identified in Car-R/Car-S mice (Nagase et al., 1995 (Nagase et al., , 2001 Peissel et al., 2001) . Therefore, there is no evidence, at the moment, to indicate that the Skts1 and the Car-R/Car-S locus on Chromosome 7 are the same locus.
A G/C single-nucleotide polymorphism in the Tyr gene coding sequence causes a Cys/Ser variation that defines the albino (Tyr Ser , Tyr À ) and the nonalbino (Tyr Cys , Tyr þ ) alleles. The Tyr Ser allele is not functional and abrogates melanin pigment production in skin and retina, causing albinism. Derived from a common mouse ancestor, the Tyr Ser allele is responsible for the recessive albino phenotype in most albino laboratory strains (Yokoyama et al., 1990) .
In the present study, we rescued the albino mutation in transgenic mice and tested the functional role of Tyr in two-stage skin carcinogenesis. Mechanistic studies in vitro on a Tyr-transfected human squamous cell carcinoma cell line point to a role for oxidative DNA damage protection of the functional Tyr allele.
Results

Tyr transgene reduces susceptibility to skin carcinogenesis
The Tyr chimeric construct comprises cis-acting regulatory elements responsible for the appropriate expression of the tyrosinase gene, cloned in front of the tyrosinase minigene (Ganss et al., 1994) . The construct is able to rescue completely the albino phenotype of recipient mice (Ganss et al., 1994) . Three transgenic founder lines were obtained by injection of the functional Tyr gene into FVB zygotes. One line was chosen for further study based on the darker agouti coat color, indicating higher levels of transgene expression. Tyr was maintained at heterozygosity in the FVB background or passed onto the Car-S background. The FVB strain has not yet been used for genetic linkage mapping of skin carcinogenicity loci, whereas Car-S mice have been shown to carry the susceptibility allele at the skin cancer-modifier locus mapping around the Tyr region (Peissel et al., 2001) . Both FVB and Car-S mice carry the albino allele at the Tyr locus.
The effects of Tyr were tested by a standard two-stage skin carcinogenesis protocol (Peissel et al., 2001) . Since skin papilloma multiplicity values were similar in both sexes, the data for males and females were grouped together. Treatment of both albino and Tyr-transgenic mice with DMBA (9,10-dimethyl-1,2-benzanthracene)/TPA (12-O-tetradecanoylphorbol-13-acetate) resulted in a time-and dose-dependent increase in skin papilloma multiplicity in both groups (Figure 1 ). Groups of Car-S mice showed a higher skin papilloma multiplicity than the corresponding groups of FVB mice treated with the same DMBA dose (2.5 mg) (Figure 1 , top panels). This result was expected, as Car-S mice have been phenotypically selected for high skin tumor susceptibility Peissel et al., 2001) ; FVB mice, although generally susceptible to skin tumors, may carry resistance alleles that could explain the observed difference in phenotypic response as compared to Car-S mice.
Time-dependent tumor multiplicity curves were fitted with a logistic regression model in order to estimate the following parameters: maximum number of papillomas/ mouse (MAXno), time required to develop the halfmaximum number of tumors (t 1 2 ), and maximum velocity of tumor development (V max ). Tyr-transgenic mice developed fewer skin papillomas than did their wild-type albino counterparts. The MAXno at any DMBA dose differed significantly (Po0.01) between FVB-Tyr À/À and FVB-Tyr þ /À mice, as well as between Car-S-Tyr À/À and Car-S-Tyr À/ þ mice (Figure 1 ). At the end of tumor promotion, MAXno was 2.3-, 1.2-, and 1.4-fold higher in FVB-Tyr À/À than FVB-Tyr þ /À mice treated with 2.5, 5.0, or 10.0 mg DMBA, respectively, and 1.2-fold higher in Car-S-Tyr À/À than in Car-S-Tyr (Table 1) .
Tyr counteracts oxidative DNA damage
The functional Tyr gene, amplified by RT-PCR from mRNA of normal skin of a C57BL/6J adult mouse (black coat color), was subcloned into a mammalian expression vector. Transfection of NCI-H520 cells with control LacZ and Tyr genes resulted in a similar number of cell clones after selection for G418 resistance, indicating that Tyr transfection had no significant effect on cell viability. Clone 5, among seven stable Tyrtransfected clones, showed the highest Tyr enzymatic activity, that is 414 (nmol/min)/mg protein, and was used for further functional studies. Tyrosinase enzymatic activity of parental and LacZ-transfected control NCI-H520 cells was below the detection limits, and that of mushroom tyrosinase (positive control) was 100.8 (mmol/min)/mg protein.
In vitro exposure of Tyr-transfected and NCI-H520 cells to various concentrations of H 2 O 2 induced a dosedependent increase in the frequency of cellular DNA Tyr: a modifier of skin carcinogenesis A Saran et al breaks in both groups, but Tyr-transfected cells showed significant resistance to H 2 O 2 -induced DNA damage, as fewer DNA breaks (P ¼ 0.0027, Figure 2a) . Moreover, the frequency of highly damaged cells (fluorescence in the comet tail 436%) was consistently higher in control than in the Tyr-transfected cells, and the difference was significant at 50 mM H 2 O 2 (74 versus 48%, P ¼ 0.0002) (Figure 2b ).
Discussion
We tested Tyr as a candidate skin tumor-modifier gene in a transgenic mouse constructed to express the functional Tyr allele in the albino background. Analysis of DMBA/TPA-induced skin carcinogenesis in Tyrtransgenic and wild-type albino mice showed that the presence of the functional Tyr allele at heterozygosity consistently decreased susceptibility to skin tumor development in four separate experiments carried out at three dose levels (Figure 1 ). The relative reduction in tumor multiplicity ranged from 1.2-to 2.3-fold, with the strongest effect at the lowest dose of DMBA (2.5 mg, Figure 1 , Table 1 ). The functional Tyr gene introduced into the albino genetic background was also able to delay the time required to develop the half-maximum number of tumors (t 1 2 ) and to reduce the maximum velocity of tumor development (V max ) ( Table 1) .
At the Car-R/Car-S locus that included the Tyr gene, the phenotypic difference in tumor multiplicity between albino and nonalbino heterozygous mice was B2.5-fold (Peissel et al., 2001) . This difference is comparable to the 2.3-fold tumor reduction observed in FVB Tyr-transgenic mice at the 2.5 mg DMBA dose, that is the same dose level at which the Chomosome 7 locus was mapped in the Car intercross (Peissel et al., 2001) . The absence of skin tumor resistance alleles in the Car-S background may account for the smaller effects of the Tyr gene in this line. Tyr gene may perhaps need interaction or cooperation with still unknown cancer-resistance alleles to fully exert its cancer-inhibiting effects.
Tyr candidacy for a skin tumor-modifier locus is supported by the segregation at homozygosity of the albino allele in the genetically heterogeneous outbred Car-S mice (Peissel et al., 2000) , and by the recessive mode of inheritance of the susceptibility allele (Peissel et al., 2001) , consistent with the recessive mode of action of the albino allele (Searle, 1990) . Moreover, two genetic linkage studies performed in genetic crosses in which both parental strains carried the same Tyr allele, either functional (Angel et al., 1997) or albino (Mock et al., 1998) , did not detect any skin tumor-modifier locus in the Tyr region; a test locus cannot exert allele-specific phenotypic effects in a cross originating from two strains carrying the same allele (Manenti et al., 1997) .
Overall, the present study and the published data strongly support the Tyr gene candidacy as a skin tumor-modifier locus. However, the possibility remains that the Car-R/Car-S locus peaking at Tyr is a multigene locus, including Tyr and additional gene(s), based on observations in other models suggesting that the functional activities of several quantitative trait loci are most likely mediated by a cluster of genes with related functions (Cormier et al., 2000; Darvasi and Pisante-Shalom, 2002; Steinmetz et al., 2002; Maria et al., 2003) .
Tyr encodes the enzyme tyrosinase that catalyses the hydroxylation of L-tyrosine to DOPA and the oxidation of DOPA to DOPA-quinone (del Marmol and Beermann, 1996) . The role of tyrosinase in two-stage skin carcinogenesis does not appear to involve metabolic activation of DMBA to an ultimate carcinogen, since previous studies demonstrated similar levels of DMBA-DNA adducts in DMBA-treated Car-S and Car-R mice (Perin et al., 1994) .
Based on previous studies demonstrating that DMBA induces formation of oxidized bases in epidermal DNA (Frenkel et al., 1995) and that oxidative stress causes DNA mutations (Lutsenko et al., 2002) , we tested whether the functional Tyr protein might protect against DMBA-induced skin tumorigenesis by inhibiting oxidative DNA damage. The comet assay is a widely used method for studying DNA damage (Collins et al., 1997) . The main advantages of this procedure as compared to other methods, such as alkaline unwinding, alkaline elution, or HPLC detection of oxidized DNA bases, are the high sensitivity (less than 0.5 breaks/10 9 Da of DNA can be detected) and the single-cell resolution. Use of the comet assay (Giovannelli et al., 2003) to determine oxidative DNA damage in human NCI-H520 cells transfected with the mouse functional Tyr allele showed that cells overexpressing Tyr enzymatic activity were significantly more resistant than controls to oxidative DNA damage, over a range of hydrogen peroxide dose levels (Figure 2) . Although the mechanism underlying this Tyr-mediated protection awaits elucidation, L-DOPA oxidation products might be involved, as suggested by the finding that incubation of mushroomextracted Tyr protein with L-DOPA protected a human lymphoma cell line against hydrogen peroxide-induced oxidative DNA damage (Shi et al., 2002) .
The putative mechanism of Tyr action through the modulation of DNA damage is supported by a wide series of studies reporting inhibition of tumor initiation and promotion by antioxidant agents on two-stage skin carcinogenesis (reviewed in Slaga, 1995) . Some of these antioxidant agents have also been found to inhibit DNA damage and formation of oxidized DNA bases (Wei and Frenkel, 1993; Park et al., 2003) .
The functional activity of Tyr as a cancer-modifier gene in mouse skin carcinogenesis throughout its capability to modulate oxidative DNA damage may suggest a novel mechanism of action of cancer-modifier loci, based on the control of exogenous or endogenous oxidative DNA damage. The possible relevance of this mechanism would be worth being tested for additional candidate cancer-modifier loci.
Materials and methods
Transgenic mice
FVB mice were purchased from Charles River (Calco, Italy). The tyrosinase gene construct phsTyr4, described to rescue the albino phenotype of transgenic mice (Ganss et al., 1994) , was used to generate transgenic lines by pronuclear DNA microinjection (Hogan et al., 1994) of the linearized phsTyr4 construct into FVB zygotes. Since FVB inbred mice are albinos, transgenic animals were screened by the acquired pigmentation due to transgene expression. The lines were propagated by crossing heterozygous transgenics to wild-type FVB partners. The Tyr transgene was then passed to the Car-S (albino) background by four cycles of breeding. The resulting albino (Car-S-Tyr À/À ) and pigmented (Car-S-Tyr þ /À ) mice of the last cross carried approximately 93.75% of the Car-S genome and were used for experiments.
Two-stage skin carcinogenesis experiment
Tyr-transgenic and albino mice (14-26 mice per group) were treated at 8-10 weeks of age with a single topical application of 2.5, 5.0, or 10 mg (FVB groups) or 2.5 mg (Car-S groups) DMBA. Beginning 7 days after DMBA initiation and continuing for 13-21 weeks, 1.0 mg TPA was applied twice each week. Time of appearance (latency), number, and incidence of papillomas were recorded at each tumor-promoting TPA treatment.
Transfection of mouse Tyr to a human cancer cell line
Total RNA was extracted from normal untreated skin of an adult male C57BL/6J mouse (Charles River, Calco, Italy) using RNAfast-II (Molecular Systems, San Diego, CA, USA). PolyA þ mRNA was isolated by Oligotex mRNA Mini kit (Qiagen, Valencia, CA, USA). cDNA was synthesized from polyA þ mRNA using Superscript-II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). The full-length coding region of Tyr mRNA (GenBank Accession # AK014619) was PCR-amplified using a forward primer including 69 nt upstream of the ATG codon (5 0 -TTGCTGGAAAA-GAAGTCTGTGA-3 0 ) and a reverse primer ending just ahead Tyr: a modifier of skin carcinogenesis A Saran et al the TGA stop codon (5 0 -CAGATGGCTCTGATACAG-CAAG-3 0 ), to produce a chimeric Tyr protein containing the V5-His epitope at the C-terminus after subcloning in the eucaryotic pcDNA3.1/V5-His-TOPO cloning vector (Invitrogen). Nucleotide sequences of the recombinant clones were determined using an ABI 377 sequencer (Applied Biosystems) and aligned using the BLAST program. A recombinant clone containing the Tyr gene nucleotide sequence identical to the reported Tyr mRNA sequence of C57BL/6 mice (GenBank Accession # AK014619) was used for transfection studies.
NCI-H520 (American Type Culture Collection, Rockville, MD, USA) cells, derived from a human squamous cell carcinoma, were transfected using Superfect s reagent (Qiagen) with 2.5 mg DNA of control pcDNA3.1/V5-HisB/LacZ expression vector (Invitrogen) or recombinant vector containing mouse Tyr. Transfected clones were propagated for 3 weeks in selective medium containing 1 mg/ml G418 (Invitrogen), methanol-fixed and stained with 10% Giemsa. Cell clones with diameter 40.5 mm were counted. Cell transfection was repeated to obtain stable transfectant clones that were isolated and propagated in selective medium.
Tyrosinase assay
Cell lysates from stable transfectant clones were prepared by resuspending cell pellets in 300 ml of lysis buffer (50 mM TrisHCl pH 7.4, 5 mM EDTA, 250 mM NaCl, 50 mM NaF, 0.1% Triton X-100, 0.1 mM Na 3 VO 4 , and 1.5 mM PMSF). Supernatants were collected by centrifugation and total protein content was measured using the Bio-Rad protein assay (BioRad, Hercules, CA, USA).
DOPA oxidase activity of tyrosinase was determined by spectrophotometry using Besthorn's hydrazone (3-methyl-2-benzothiazolinone hydrazone) as described (Winder, 1994) . Mushroom tyrosinase (2 mg) was used as a positive control. One unit of enzyme activity is defined as the amount of enzyme required to produce 1 mole of pigment product per min (e 505 ¼ 29.0 Â 10 3 M À1 cm
À1
) under the conditions of the assay (Winder, 1994) .
Assessment of oxidative DNA damage
Single-strand breaks in cells were determined by alkali singlecell gel electrophoresis (comet assay) as described (Giovannelli et al., 2003) . The assay is based on alkaline lysis of labile DNA at sites of damage (i.e., from oxidation). Control or Tyrtransfected cells (10 5 ) were plated in a 12-well plate. On the day of the experiment, cells were washed with PBS and treated with 0, 5, 12.5, 25, or 50 mM H 2 O 2 diluted in PBS. After incubation on ice for 15 min, cells were washed with PBS and harvested. Pellets were resuspended in 100 ml PBS, and 5-ml aliquots of each sample were used to check cell viability with Trypan blue.
The remaining cell suspension was further centrifuged and resuspended in 140 ml of low-melting point agarose (1%); two gels (70 ml each) were prepared, covered with 18 Â 18-mm coverslips, solidified and run. The comet assay and microscopy analysis were carried out as described (Giovannelli et al., 2003) . For each sample, 100 nuclei were measured (50 nuclei per gel). DNA damage was expressed as the percentage of total fluorescence migrated in the tail for each nucleus.
Statistical analysis
The observed number of skin tumors (y) as a function of time (t, expressed in log units) was fitted with a three-constant logistic model:
where a is the maximum number of tumors (MAXno), t is the time required to develop the half-maximum number of tumors (t 1 2 ), b is the maximum velocity of tumor development (V max ), and e(t) is a random error term. The observed percent DNA migrated in the tail of the comet as a function of H 2 O 2 concentration (expressed in log scale) was fitted with a sixconstant logistic model, similar to that described above. Among the constants, the estimates of baseline (damage in the absence of H 2 O 2 ) and EC 50 (concentration required to obtain the half-maximum damage) were common to the two types of cells, whereas the increase in EC 50 and maximum damage were estimated for the two types separately. For both models, nonlinear least-squares estimates of the constants were obtained by means of SAS PROC NLIN (SAS/STAT User's Guide, Version 8, Cary, NC, USA); approximate 95% confidence limits for logistic curves were computed according to Draper and Smith (1981) .
Abbreviations DMBA, 9,10-dimethyl-1,2-benzanthracene; DOPA, 3,4-dihydroxyphenylalanine; Skts1, skin tumor susceptibility 1; TPA, 12-O-tetradecanoylphorbol-13-acetate; Tyr, tyrosinase.
